Literature DB >> 31931758

Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.

Ji-Gang Zhang1, He-Ming Zhou1, Xue Zhang1, Wan Mu1, Juan-Ni Hu1, Gao-Lin Liu2, Qin Li3.   

Abstract

BACKGROUND: Vasculogenic mimicry (VM), defined as a capability of aggressive tumor Cells to mimic embryonic vasculogenic networks, caused poor prognosis in hepatocellular carcinoma (HCC). Rho kinases (ROCK), p21-activated kinase (PAK), hypoxia or epithelial-mesenchymal transition (EMT) contributed to the VM potential. However, the details underlying these biological behaviors have not been completely elucidated.
METHODS: Kaplan-Meier analysis was conducted to predict relationship with hypoxia Inducible factor (HIF-1α), EMT related markers: Vimentin and patient prognosis. CD34/periodic acid-Schiff (PAS) double staining was examined to differentiate VM-positive (VM+) and VM-negative (VM-) samples. Cells were cultured under controlled hypoxic environments (1% O2) or normoxic conditions. The effect of hypoxia on RhoA/ROCK, Rac1/PAK and EMT were evaluated by real time-qPCR and western blot. HIF-1α small interfering RNA (siRNA), overexpressed or short hairpin RNA (shRNA) of ROCK and kinase inhibitors were used to explore the effect of HIF-1α, RhoA/ROCK, Rac1/PAK and Vimentin on VM.
RESULTS: HIF-1α or Vimentin was upregulated in VM+ HCC tissues, compared to non-cancerous tissues (P < 0.01), and patients with high expression of HIF-1α or Vimentin had worse prognosis (P < 0.001). We showed hypoxia induced RhoA/ROCK and Rac1/PAK signaling transduction, and EMT could be repressed by HIF-1α siRNA. Notably, RhoA/ROCK or Rac1/PAK stabilized HIF-1α in hypoxia, whereas HIF-1α did not significantly altered RhoA/ROCK or Rac1/PAK signaling in hypoxia. Moreover, we found distinct roles of ROCK1, ROCK2 and PAK in regulating Vimentin phosphorylation.
CONCLUSIONS: RhoA/ROCK and Rac/PAK signaling played crucial roles in hypoxia-induced VM via Ser72 and Ser56 Vimentin phosphorylation in HCC.

Entities:  

Keywords:  HIF-1α; Rac1/PAK; RhoA/ROCK; Vimentin;Vasculogenic mimicry

Year:  2020        PMID: 31931758     DOI: 10.1186/s12885-019-6501-8

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  13 in total

1.  Lupeol and Paclitaxel cooperate in hindering hypoxia induced vasculogenic mimicry via suppression of HIF-1α-EphA2-Laminin-5γ2 network in human oral cancer.

Authors:  Depanwita Saha; Debarpan Mitra; Neyaz Alam; Sagar Sen; Saunak Mitra Mustafi; Pradip K Majumder; Biswanath Majumder; Nabendu Murmu
Journal:  J Cell Commun Signal       Date:  2022-09-05       Impact factor: 5.908

2.  Treatment for Liver Tumor Using Combined Transarterial Embolization and Interaarterial Transfecting HIF-1α shRNA in a Rabbit VX2 Model.

Authors:  Chuangen Guo; Cheng Wang; Jingfeng Zhang; Xiao Chen
Journal:  Onco Targets Ther       Date:  2020-08-24       Impact factor: 4.147

Review 3.  Novel Molecular Mechanisms of Pulmonary Hypertension: A Search for Biomarkers and Novel Drug Targets-From Bench to Bed Site.

Authors:  Damian Gajecki; Jakub Gawrys; Ewa Szahidewicz-Krupska; Adrian Doroszko
Journal:  Oxid Med Cell Longev       Date:  2020-05-22       Impact factor: 6.543

4.  Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosis.

Authors:  Jingjing Liu; Jin Zhang
Journal:  Ann Transl Med       Date:  2021-01

5.  USP14 maintains HIF1-α stabilization via its deubiquitination activity in hepatocellular carcinoma.

Authors:  Chi Lv; Shengli Wang; Lin Lin; Chunyu Wang; Kai Zeng; Yiming Meng; Ge Sun; Shan Wei; Yefu Liu; Yue Zhao
Journal:  Cell Death Dis       Date:  2021-08-21       Impact factor: 8.469

6.  Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and RhoA.

Authors:  Junyi Wang; Lichan Yuan; Xiaohong Xu; Zhongyin Zhang; Yuhuan Ma; Leilei Hong; Junqing Ma
Journal:  Cell Death Dis       Date:  2021-12-11       Impact factor: 8.469

7.  Inward Outward Signaling in Ovarian Cancer: Morpho-Phospho-Proteomic Profiling Upon Application of Hypoxia and Shear Stress Characterizes the Adaptive Plasticity of OVCAR-3 and SKOV-3 Cells.

Authors:  Andrea Bileck; Patricia Bortel; Michelle Kriz; Lukas Janker; Endre Kiss; Christopher Gerner; Giorgia Del Favero
Journal:  Front Oncol       Date:  2022-02-14       Impact factor: 6.244

8.  MiR-29a Curbs Hepatocellular Carcinoma Incidence via Targeting of HIF-1α and ANGPT2.

Authors:  Ying-Hsien Huang; Wei-Shiung Lian; Feng-Sheng Wang; Pei-Wen Wang; Hung-Yu Lin; Ming-Chao Tsai; Ya-Ling Yang
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

9.  CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways.

Authors:  Lixia Chen; Xiaoli Long; Shiyu Duan; Xunhua Liu; Jianxiong Chen; Jiawen Lan; Xuming Liu; Wenqing Huang; Jian Geng; Jun Zhou
Journal:  Theranostics       Date:  2020-09-02       Impact factor: 11.556

10.  uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells.

Authors:  Elena Andreucci; Anna Laurenzana; Silvia Peppicelli; Alessio Biagioni; Francesca Margheri; Jessica Ruzzolini; Francesca Bianchini; Gabriella Fibbi; Mario Del Rosso; Chiara Nediani; Simona Serrat; Livia Fucci; Michele Guida; Lido Calorini
Journal:  Oncol Res       Date:  2021-07-27       Impact factor: 5.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.